Journal
CHEMICAL BIOLOGY & DRUG DESIGN
Volume 96, Issue 6, Pages 1433-1446Publisher
WILEY
DOI: 10.1111/cbdd.13752
Keywords
antitumor activity; apoptosis; indole-4,7-quinone derivatives; quinone oxidoreductase 1; reactive oxygen species; beta-Carboline
Funding
- Project of Jiangsu Pharmaceutical Association [A2017016]
- Science and technology project of Nantong City [MS12018077, MS12018058, JC2018125]
Ask authors/readers for more resources
Eighteen new beta-carboline-based indole-4,7-quinone derivatives (12a-iand13a-i) were designed and synthesized, and their in vitro and in vivo antiproliferative activities were studied. Most of target compounds showed strong inhibition on three human tumor cells' proliferation. In particular, the most active compound13gnot only displayed more prominent antiproliferative activities than beta-lapachone, a clinical antitumor candidate, but also exerted significant NAD(P)H: quinone-oxidoreductase-1 (NQO1) inhibitory activity and NQO1-dependent cytotoxicity in HT29 cells. Furthermore,13gdose-dependently induced high ROS levels in HT29 cells, and selectively inhibited cancer cell but not non-tumor colon cell proliferation in vitro. Importantly,13gpromoted HT29 cell apoptosis and DNA damage by regulating relative apoptotic proteins and H2AX expression. Finally,13gdisplayed significant growth inhibition of HT29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available